Aramis Biosciences
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $11M
Investors
- 1
About Aramis Biosciences
Aramis Biosciences, Inc.Aramis Biosciences, Inc. is a clinical-stage company founded in 2018, headquartered in Boston, US. The company specializes in developing therapies for ocular surface diseases.Aramis Biosciences specializes in the development of disease-modifying therapies for ocular surface diseases, focusing primarily on Dry Eye Disease (DED). They are advancing A197, a lead product candidate in clinical trials aimed at addressing unmet medical needs in DED.S.8 million diagnosed DED patients, with fewer than 1 million receiving FDA-approved therapies.Aramis Biosciences operates as a clinical-stage company, emphasizing the development and potential commercialization of its therapies. Revenue strategies may include partnerships with pharmaceutical firms and healthcare institutions to advance A197 and other candidates.In December 2021, Aramis Biosciences, Inc. Future plans may also involve expanding into international markets as development progresses, enhancing their presence in ophthalmology and related sectors.
Who invested in Aramis Biosciences
1 investor across 2 rounds
See all investors in Aramis Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aramis Biosciences
Who invested in Aramis Biosciences?
Aramis Biosciences has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aramis Biosciences raised?
Aramis Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aramis Biosciences last raise money?
Aramis Biosciences's most recent round on record is a Series A, in Dec 2021.
What does Aramis Biosciences do?
Aramis Biosciences is a biotechnology company.
Where is Aramis Biosciences headquartered?
Aramis Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Aramis Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aramis Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aramis Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.